We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Improved Vector Expresses Long Double-Strand RNA

By Biotechdaily staff writers
Posted on 19 Jun 2003
Scientists have reported the development of a vector for insertion of double-strand RNA (ds-RNA) for use in RNAi (RNA interference) gene control in a tissue-specific manner that does not trigger the interferon response, which non-specifically degrades mRNA (messenger RNA) in response to the presence of ds-RNA in the cell.
This vector, called pDECAP, is able to express long ds-RNA from an RNA polymerase II (Pol II) promoter. More...
It was developed by researchers at the Riken Tsukuba Institute (Japan) and was described in the June 1, 2003, issue of Genes & Development.

Since the transcripts from pDECAP lack both the 5'-cap structure and the 3'-poly(A) tail that facilitate ds-RNA export to the cytoplasm, long ds-RNA from pDECAP does not induce the interferon response. Transgenic mice embryos expressing long ds-RNA for the transcriptional co-repressor Ski from this vector exhibited phenotypes that were remarkably similar to those of Ski-deficient embryos, including defects of neural tube closure and eye formation.

Senior author Dr. Shunsuke Ishii, a senior researcher at the Riken Tsukuba Institute explained, "In the RNAi transgenic systems developed so far, small hairpin-type RNA is expressed from the RNA polymerase III promoter or the virus promoter. However, these systems cannot be utilized to knock down gene function in a tissue-specific manner, because these promoters are active in all types of cells. In our system, the RNA polymerase II promoter is utilized to express hairpin-type double-strand RNA (ds-RNA). Therefore, our system can be used to generate the tissue-specific knock-down mice.”




Related Links:
Riken Tsukuba Institute

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Portable POCT Blood Gas Analyzer
BD100
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.